CILK1 and neoplasm: Another study reported that soluble PD-1, PD-L1, BTLA, BTN3A1, and pan-BTN3As levels in plasma could predict survival in 59 PDAC patients, suggesting that these soluble immune checkpoint (ICK)-related proteins could be involved in anti-tumor immunity in PDAC (16).